2009 annual financial data
Halozyme Therapeutics 2009 Operating margin
Direct answer
Operating margin was -427.6%.
Operating income was -58,458,260 USD and net income was -58,360,523 USD.
Operating cash flow was -40,148,265 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,671,305 USD
- Operating income
- -58,458,260 USD
- Net income
- -58,360,523 USD
- Operating cash flow
- -40,148,265 USD